Skip to main content
. Author manuscript; available in PMC: 2016 Mar 2.
Published in final edited form as: Mol Pharm. 2015 Jan 27;12(3):742–750. doi: 10.1021/mp500581r

Figure 6.

Figure 6

DLS measurements of siRNA/co-oligomer complexes formed with 12 over time. Particle size and stability over time of the noncovalent complexes can be controlled by counterion exchange from TFA to chloride or with 5 mol % PEG-initiated 15 incorporation. Particles were formulated at 4.77:1 ± charge ratio.